Ischemia
163
7
12
102
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
14 trials with published results (9%)
Research Maturity
102 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.1%
10 terminated out of 163 trials
91.1%
+4.6% vs benchmark
13%
22 trials in Phase 3/4
14%
14 of 102 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 102 completed trials
Clinical Trials (163)
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
Detecting Tissue Ischemia in Reconstruction Flaps by a Novel CO2 Biosensor (DIMENSION-study)
Early Discovery of Ischemia After Replantation Surgery of the Extremities
mHealth-CArdiac REhabilitation for INOCA
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
WARRIOR Ancillary Study for CCTA Analysis
Evaluation of the ORTHO-LBNP System
Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
The ORCHESTRATE-Myocarditis Registry
Study of Circulating Monocytes in Patients With Ischemic Vascular Disease
Circulating Markers for Ischemic Heart Disease
Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
Evaluation of Patients With Non-obstructive Coronary Arteries
Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study
Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children
Goal-directed CPR Using Cerebral Oximetry
Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking
Safety and Efficacy Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-2)